Relapsed/Refractory Sarcomas

1 clinical trials · Condition

Record	Firm	Date
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors (NCT01294670)	Memorial Sloan Kettering Cancer Center	2011-02-09

Every clearance here is in the API, with alerts when new ones post.